The following table details the trading activities
(stock purchases, stock sales, and stock option exercises)
the Securities and Exchange Commission (SEC)
by insider Brady Todd C since year 2005.
The trader's CIK number is 1579179.
At the time of this reporting, Brady Todd C is the President and CEO of Aldeyra Therapeutics, Inc. .
(stock ticker symbol ALDX).
See this page for all insider trading activities at Aldeyra Therapeutics, Inc. .
|Trade Date||Symbol||Company Name (Issuer)||Trade Type||Shares||Price ($)||Value ($)|
|2017-02-17||ALDX||Aldeyra Therapeutics, Inc.||Buy||22,223||4.50||100,003|
|2016-11-09||ONS||Oncobiologics, Inc.||Option Ex||28,985||.00||0|
|2014-09-23||EVOK||Evoke Pharma Inc||Buy||4,000||5.70||22,800|
|2014-05-07||ALDX||Aldeyra Therapeutics, Inc.||Buy||12,500||8.00||100,000|
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Brady Todd C (President and CEO of Aldeyra Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.